These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30607326)

  • 21. Antidoping Science: Important Lessons From the Medical Sciences.
    Simon P; Neuberger EW; Wang G; Pitsiladis YP
    Curr Sports Med Rep; 2018 Oct; 17(10):326-331. PubMed ID: 30300193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Netnography and a Survey on Doping Use among Competitive Doping-untested Strength-sport Athletes.
    Jokipalo I; Khudayarov A
    Int J Sports Med; 2021 Jun; 42(7):645-650. PubMed ID: 33506442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
    Morente-Sánchez J; Zabala M
    Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.
    Nikolopoulos DD; Spiliopoulou C; Theocharis SE
    Fundam Clin Pharmacol; 2011 Oct; 25(5):535-63. PubMed ID: 21039821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of emerging patterns of drug misuse in sports via wastewater monitoring: A mini-review and potential strategies.
    Chang WC; Hsu MC; Liao PC
    Environ Pollut; 2023 Sep; 333():122087. PubMed ID: 37348696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Illicit drugs and cardiac arrhythmias in athletes.
    Furlanello F; Serdoz LV; Cappato R; De Ambroggi L
    Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):487-94. PubMed ID: 17667636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Doping in elite and popular sport : What orthopedic and trauma surgeons should know].
    Husen M; Jäger M
    Orthopade; 2019 Aug; 48(8):711-724. PubMed ID: 31346643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doping in Sport-Attitudes of Physical Trainers Students Regarding the Use of Prohibited Substances Increasing Performance.
    Zmuda Palka M; Bigosińska M; Siwek M; Angelova-Igova B; Mucha DK
    Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidoping program: an important factor in the promotion and protection of the integrity of sport and athlete's health.
    Mazzeo F; Monda V; Santamaria S; Nigro E; Valenzano A; Villano I; Cibelli G; Messina A; Messina G
    J Sports Med Phys Fitness; 2018; 58(7-8):1135-1145. PubMed ID: 28738670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacists supporting athletes: a scoping review exploring the knowledge, role and responsibilities of pharmacists in preventing the unintentional use of prohibited substances by athletes.
    Greenbaum DH; McLachlan AJ; Roubin RH; Chaar BB
    Int J Pharm Pract; 2022 May; 30(2):108-115. PubMed ID: 35262700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of black market products and potential doping agents in Germany 2010-2013.
    Krug O; Thomas A; Walpurgis K; Piper T; Sigmund G; Schänzer W; Laussmann T; Thevis M
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1303-11. PubMed ID: 25168622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clarification of the Relationship between Awareness of Doping of Competitive Sports Coaches and Their Instructions to Prevent Doping].
    Yamaguchi T; Horio I; Goto M; Miyauchi Y; Izushi F
    Yakugaku Zasshi; 2016; 136(8):1185-93. PubMed ID: 27477736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pheromones: a new ergogenic aid in sport?
    Papaloucas M; Kyriazi K; Kouloulias V
    Int J Sports Physiol Perform; 2015 Oct; 10(7):939-40. PubMed ID: 25710097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.
    Kondric M; Sekulic D; Petroczi A; Ostojic L; Rodek J; Ostojic Z
    Subst Abuse Treat Prev Policy; 2011 Oct; 6():27. PubMed ID: 21988896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current anti-doping policy: a critical appraisal.
    Kayser B; Mauron A; Miah A
    BMC Med Ethics; 2007 Mar; 8():2. PubMed ID: 17394662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in dietary supplement use among athletes selected for doping controls.
    Lauritzen F; Gjelstad A
    Front Nutr; 2023; 10():1143187. PubMed ID: 37006918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sport-Specific Use of Doping Substances: Analysis of World Anti-Doping Agency Doping Control Tests between 2014 and 2017.
    Aguilar-Navarro M; Salinero JJ; Muñoz-Guerra J; Plata MDM; Del Coso J
    Subst Use Misuse; 2020; 55(8):1361-1369. PubMed ID: 32186429
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence, knowledge and attitude of prohibited substances use (doping) among Saudi sport players.
    Al Ghobain M; Konbaz MS; Almassad A; Alsultan A; Al Shubaili M; AlShabanh O
    Subst Abuse Treat Prev Policy; 2016 Apr; 11():14. PubMed ID: 27083557
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.